Potential of fumarate reductase as a novel therapeutic target in Helicobacter pylori infection

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.6, Iss.2, 2002-04, pp. : 135-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel therapeutic targets in Helicobacter pylori

By Loughlin Michael F

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 6, 2003-12 ,pp. : 725-735

Informa Healthcare

Access to resources Recommend Favorite

A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule

By Boer Wink A de

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 8, 2001-08 ,pp. : 1559-1566

Informa Healthcare

Access to resources Recommend Favorite

Helicobacter pylori Infection and Migraine: Possible Role in Aetiology and Therapeutic Implications

By Gerardino L.

CNS Drugs, Vol. 13, Iss. 2, 2000-02 ,pp. : 97-101

Adis International

Access to resources Recommend Favorite

Clarithromycin for Helicobacter pylori infection

By Leung W.K. Graham D.Y.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 507-514

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Cholesteryl O-acyl -glucoside Found in Helicobacter pylori

Current Medicinal Chemistry, Vol. 19, Iss. 28, 2012-10 ,pp. : 4869-4874

Bentham Science Publishers

Access to resources Recommend Favorite